Dermanolon 1.77 mg/ml + 17.7 mg/ml Cutaneous Spray, Solution for Dogs and Cats

At the beginning of treatment, existing scale and or exfoliative debris should be
removed. Hair surrounding or covering the lesions may need to be clipped to
enable the veterinary medicinal product to reach the affected skin.

Revised: February 2025
AN: 01615/2023
Seborrhoeic dermatitis may be a primary disorder, but can also occur as a result
of underlying disorders or disease processes (e.g. allergic disorders, endocrine
disorders, neoplasia). Furthermore, infections (bacterial, parasitic or fungal)
commonly occur concurrently with seborrhoeic dermatitis. Therefore it is
essential to identify any underlying disease process and initiate specific
treatment if considered necessary.

Special precautions for use in animals
As the minimum bodyweight for the treatment is 3,5 kg, this product will not be
suitable for use in certain patients, such as smaller dogs and cats or those with
extensive lesions. Please check maximum recommended dose in section 4.9.
Systemic corticosteroid effects are possible, especially when the product is
used under an occlusive dressing, on extensive skin lesions, with increased
blood flow, or if the product is ingested by licking. Oral ingestion (including
licking) of the product by treated animals or animals having contact with treated
animals should be avoided. Additional corticosteroid treatment should be used
only according to the benefit/risk assessment of the responsible veterinarian.
Use with precaution in animals with suspected or confirmed endocrine disorders
(i.e. diabetes mellitus; hypo- or hyper-thyroidism, hyperadrenocorticism etc.).
Since glucocorticosteroids are known to slow growth, use in young animals
(under 7 months of age) should be based on a benefit/risk assessment by the
attending veterinarian and subject to regular clinical re-evaluations.
Do not apply in the eyes or on the mucosa. Do not apply the veterinary
medicinal product on damaged skin.
Special precautions to be taken by the person administering the veterinary
medicinal product to animals
This product contains triamcinolone acetonide, salicylic acid and ethanol and
may be harmful to children after accidental ingestion. Do not leave the product
unattended. In case of accidental ingestion seek medical advice immediately
and show the package leaflet or label to the physician.
This product may be harmful to the unborn child. As the product can be
absorbed through the skin, pregnant women and women of childbearing
potential should not handle this product or restrain the animal during treatment
and should avoid contact with the treated animal until at least 4 hours after the
application.
This product may be irritating to skin or induce hypersensitivity reactions.
People with known hypersensitivity to corticosteroids or salicylic acid should
avoid contact with the product.
Avoid skin contact with the product. Wear single-use impermeable gloves when
handling the product including rubbing in the affected skin of the animal or
restraining the animal during treatment. If contact occurs, wash hands or
exposed skin and seek medical advice in case of hypersensitivity reactions or if
irritation persists.

Revised: February 2025
AN: 01615/2023
This product may be irritating to the eyes. Avoid contact with the eyes including
hand-to-eye contact. If contact occurs, rinse with clean water. If eye irritation
persists, seek medical advice and show the package leaflet or label to the
physician.
This product may be harmful after inhalation, especially for people with asthma.
Spray in well-ventilated area. Avoid breathing in the spray-mist.
Treated animals should not be handled and children should not be allowed to
play with treated animals until the application site is dry. It is recommended that
recently treated animals should not be allowed to sleep with owners, especially
children.
Special precautions for the protection of the environment
Not applicable
Other precautions
Not applicable